SCHEDULE 13G

Company

Finch Therapeutics Group, Inc.

Filed

December 13, 2023

Accession Number

0001014108-23-000151

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →